PYXS — PYXIS ONCOLOGY INC

Ownership history in STEMPOINT CAPITAL LP  ·  4 quarters on record

This page tracks every 13F SEC filing in which STEMPOINT CAPITAL LP reported a position in PYXIS ONCOLOGY INC (PYXS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
2.02% (2024 Q1)
Avg. % of fund
1.11%
First filed
2024 Q1
Last filed
2025 Q3
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 689,538 -160,672 -18.9% 0.31% $1.5M $2.22
2024 Q3 REDUCED 850,210 -352,465 -29.3% 0.93% $3.1M $3.67
2024 Q2 REDUCED 1,202,675 -591,520 -33.0% 1.17% $4.0M $3.31
2024 Q1 INITIATED 1,794,195 — — 2.02% $7.6M —
% of Fund (quarterly)    PYXS price (monthly, adj. close)

Other funds also holding PYXS

As of 2025 Q4 — sorted by position size

Ridgeback Capital Investments L.P. 3Y 7Y 100.0% PFIZER INC 3.42% GordonMD Global Investments LP 3.4% Atle Fund Management AB 3Y 7Y 0.23% Laurion Capital Management LP 3Y 7Y 0.17% Palo Alto Investors LP 3Y 7Y 0.17% Decheng Capital LLC 0.05% Longaeva Partners L.P. 0.05% 683 Capital Management, LLC 3Y 7Y 0.04% UNIVERSITY OF CHICAGO 3Y 7Y 0.03%
← Back to STEMPOINT CAPITAL LP Holdings